Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 223.83B | 214.31B | 175.47B | 147.47B | 152.82B | 204.63B |
Gross Profit | 25.11B | 23.68B | 4.24B | 4.61B | 4.50B | 22.69B |
EBITDA | 28.56B | 12.25B | -2.16B | -9.27B | -3.99B | 14.08B |
Net Income | -5.86B | -313.00M | -13.66B | -19.03B | -17.08B | -2.02B |
Balance Sheet | ||||||
Total Assets | 158.48B | 142.04B | 148.82B | 142.93B | 145.54B | 150.69B |
Cash, Cash Equivalents and Short-Term Investments | 33.28B | 24.12B | 32.87B | 27.94B | 21.32B | 22.70B |
Total Debt | 82.68B | 74.32B | 79.69B | 71.12B | 60.39B | 47.13B |
Total Liabilities | 131.26B | 119.61B | 127.51B | 111.13B | 98.10B | 85.70B |
Stockholders Equity | 16.78B | 12.36B | 11.48B | 22.33B | 38.66B | 55.99B |
Cash Flow | ||||||
Free Cash Flow | 3.49B | -4.26B | -5.39B | -3.71B | -14.29B | -6.21B |
Operating Cash Flow | 3.49B | -547.00M | -1.90B | 2.07B | -4.22B | 6.88B |
Investing Cash Flow | 0.00 | 871.00M | 2.74B | -3.60B | -7.54B | -11.95B |
Financing Cash Flow | 0.00 | -10.74B | 2.34B | 6.24B | 10.27B | 8.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥150.79B | 10.67 | 6.70% | 3.67% | -1.01% | 0.48% | |
75 Outperform | $3.43T | 8.12 | 15.02% | 2.40% | 8.39% | 55.79% | |
73 Outperform | $1.88T | 5.63 | 12.64% | 5.20% | -0.37% | -10.12% | |
71 Outperform | $1.02T | 12.71 | 7.19% | 4.65% | 4.48% | -51.81% | |
67 Neutral | ¥253.98B | 13.04 | 6.57% | 2.83% | 5.07% | -11.36% | |
67 Neutral | $598.38B | 14.30 | 4.11% | 3.65% | -0.05% | -73.27% | |
39 Underperform | ¥3.64B | ― | ― | 33.86% | 69.12% |